Heron Therapeutics Announces Presentation at 43rd Annual Cowen Healthcare Conference

Rhea-AI Summary

Heron Therapeutics, Inc. (Nasdaq: HRTX) has announced participation in a fireside chat at the 43rd Annual Cowen Healthcare Conference on March 7, 2023, at 2:10 PM ET in Boston, MA. The live webcast will be available on their website. Heron Therapeutics is a commercial-stage biotechnology firm focused on developing innovative treatments to address significant unmet patient needs, particularly in acute care and oncology. The company leverages advanced science and patented technologies to enhance patient care standards. For further details, visit www.herontx.com.

Positive

• Participation in a notable healthcare conference highlights company visibility and engagement with investors.
• Focused on unmet patient needs, indicating a strong market demand for Heron's therapeutic innovations.

Negative

• None.

SAN DIEGO, Feb. 27, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that company management will participate in a fireside chat on Tuesday, March 7, 2023 at 2:10 PM ET at the 43^rd Annual Cowen Healthcare Conference, being held March 6-8^th, 2023 in Boston, MA.

A live webcast of the fireside chat will be available on the Company's website at www.herontx.com in the Investor Resources section.

About Heron Therapeutics, Inc.

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit www.herontx.com.

Forward-looking Statements

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit www.herontx.com.

Investor Relations and Media Contact:
David Szekeres
Executive Vice President, Chief Operating Officer
Heron Therapeutics, Inc.
dszekeres@herontx.com
858-251-4447

View original content:https://www.prnewswire.com/news-releases/heron-therapeutics-announces-presentation-at-43rd-annual-cowen-healthcare-conference-301757097.html

SOURCE Heron Therapeutics, Inc.

FAQ

When will Heron Therapeutics participate in the Cowen Healthcare Conference?

Heron Therapeutics will participate in the Cowen Healthcare Conference on March 7, 2023, at 2:10 PM ET.

Where is the Cowen Healthcare Conference being held?

The Cowen Healthcare Conference is being held in Boston, MA, from March 6-8, 2023.

What is the focus of Heron Therapeutics?

Heron Therapeutics focuses on developing best-in-class treatments for unmet patient needs in acute care and oncology.

Is the fireside chat available for streaming?

Yes, a live webcast of the fireside chat will be available on Heron Therapeutics' website.